Oragenics (United States)

An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II

Hester E. Hasper, Naomi E. Kramer, Leif Smith et al. · Science · 2006 · 493 citations · Full text

Lipid Ii, Engineering, Antibiotic Adjuvant +16

Preliminary assessment of safety and effectiveness in humans of ProBiora³ ™, a probiotic mouthwash

R.T. Zahradnik, I. Magnusson, Clay Walker et al. · Journal of Applied Microbiology · 2009 · 92 citations

Identification of In Vivo-Induced Bacterial Protein Antigens during Human Infection with <i>Salmonella enterica</i> Serovar Typhi

Jason B. Harris, Andrea Baresch-Bernal, Sean M. Rollins et al. · Infection and Immunity · 2006 · 74 citations · Full text

Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective study

Gregory Reardon, Gail F. Schwartz, Essy Mozaffari · Clinical Therapeutics · 2003 · 68 citations

Ocular Disease, Ophthalmology, Eye Health +4

Pharmacodynamic activity of the lantibiotic MU1140

Oliver Ghobrial, Hartmut Derendorf, Jeffery D. Hillman · International Journal of Antimicrobial Agents · 2008 · 61 citations · Full text

Medicine, Antibiotic Adjuvant, Mechanism Of Action +5